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Abstract
Background:  The parasitic protozoa belonging to Leishmania (L.) donovani complex possess
abundant, developmentally regulated cathepsin L-like cysteine proteases. Previously, we have
reported the isolation of cysteine protease gene, Ldccys2 from Leishmania (L.) chagasi. Here, we
have further characterized this cysteine protease gene and demonstrated its role during infection
and survival of Leishmania (L.) chagasi within the U937 macrophage cells.
Results: The amastigote specific Ldccys2 genes of L. (L.) chagasi and L. (L.) donovani have identical
gene organization, as determined by southern blots. In vivo expression analyses by Northern blots
showed that Ldccys2 is amastigote specific. Western blot using anti-Ldccys2 antibody confirmed the
amastigote specific protein expression. Recombinant expression of Ldccys2, a 30 kDA protein, was
functionally active in a gelatin assay. Results from Ldccys2 heterozygous knockout mutants showed
its role during macrophage infection and in intra-macrophage survival of the parasites. Since
attempts to generate null mutants failed, we used antisense RNA inhibition to regulate Ldcccys2
gene expression. Not surprisingly, the results from antisense studies further confirmed the results
from heterozygous knockout mutants, reiterating the importance of amastigote specific cysteine
proteases in Leishmania infection and pathogenesis.
Conclusions: The study shows that Ldccys2 is a developmentally regulated gene and that Ldccys2
is expressed only in infectious amastigote stages of the parasite. The collective results from both
the heterozygous knockout mutants and antisense mRNA inhibition studies shows that Ldccys2
helps in infection and survival of L. (L.) chagasi amastigotes within the macrophage cells. Finally,
antisense RNA technique can be used as an alternate approach to gene knockout, for silencing gene
expression in L. (L.) chagasi, especially in cases such as this, where a null mutant cannot be achieved
by homologous recombination.
Background
Leishmania are the etiological agents of a variety of disease
manifestations, collectively termed as leishmaniasis. Vis-
ceral leishmaniasis caused by Leishmania (L.) donovani
and Leishmania (L.) chagasi is a serious health problem in
many tropical and subtropical countries [1-3]. During the
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digenetic life cycles of Leishmania, it alternates between
gut of sand fly vector as an extra cellular promastigote and
in the acidic phagolysosome of macrophage as an intrac-
ellular amastigote. However, the most intriguing question
is the capacity of Leishmania to withstand the hydrolytic
conditions of the macrophages, the mechanism of which
is still unclear. Thus, identifying the genes expressed spe-
cifically in the amastigote stage of the parasites and eluci-
dating their biological function is very important as it
would provide new insights into the role of these gene
products in the intracellular life cycle of the parasites. Fur-
ther, this will also help in designing specific drugs and
identifying vaccine candidates.
Cysteine proteases play an important role in the infection,
replication, development and metabolism of protozoan
parasites [4,5]. They have been implicated in the invasion
of human erythrocyte by Plasmodium falciparum [6] and
considered as virulence factors in the pathogenesis of
Entamoeba histolytica [7]. Cysteine protease activity is nec-
essary for the survival of Leishmania (L.) mexicana [8,9]
and related protozoan, Trypanosoma cruzi, within the mac-
rophages, in vitro [10]. Knockout studies in L. (L.) mexi-
cana  have shown that cysteine proteases not only are
virulence factors but also act as modulators of host
immune responses [11,12]. Thus, cysteine proteases have
become a potential target for chemotherapy and a candi-
date for vaccine development. Initial studies have con-
firmed the efficacy of cysteine protease inhibitors in
treatment of T. cruzi, P. falciparum and L. (L.) major [13-
15]. Immunization with the hybrid protein vaccine, con-
sisting of L. (L.) major cysteine proteases CPB and CPA,
partially protected against leishmaniasis [16]. So far, func-
tionally well characterized cysteine proteases are from the
New World species of Lesihamania causing the cutaneous
forms of leishmaniasis. The members of L .(L.) donovani
complex also possess multiple classes of cysteine pro-
teases, which are developmentally regulated [17,18] and
are not functionally well characterized. Therefore, there is
a need to study the function of these proteases and their
role in visceral leishmaniasis.
Studies aimed at defining the function of protozoan para-
site components have often used gene disruption
approach by homologous recombination. Recently an
alternative antisense RNA method was followed that may
easily and rapidly answer the complex biological ques-
tions. Anti sense RNA approach has been used to study the
functions of certain gene products in Entamoeba and Leish-
mania, to elucidate the functions of cysteine protease
[19,20], A2 protein [21] and gp63 [22]. Previously, we
have isolated and characterized two distinct cysteine pro-
tease cDNA clones Ldccys1 and Ldccys2 from promastigote
and amastigote specific cDNA libararies of L. (L.) chagasi
[17]. Ldccys1, a member of multi gene family was charac-
terized both in L. (L.) chagasi (Ldccys1) and L. (L.) dono-
vani (Lddcys1) parasites [18]. In the present study, we have
characterized the functional role of amastigote specific
cysteine protease gene (Ldccys2) of L. (L.) chagasi. We have
generated Ldccys2 heterozygous knockout mutants of L.
(L.) chagasi by homologous recombination. As an alterna-
tive approach, antisense mRNA expression was also
employed. Results obtained from both, gene disruption
and antisense mRNA expression shows that Ldccys2 plays
an important role in the survival of amastigotes within the
U937 macrophages.
Results
Ldccys2 is a single copy gene
From our earlier studies it is known that Ldccys2 is a single
copy gene in L. (L.) chagasi. In order to compare the
genomic organization of Ldccys2 gene in L. (L.) donovani
and L. (L.) chagasi, the members of L. (L.) donovani com-
plex, Southern analysis of genomic DNA was performed.
Genomic DNA was digested with different restriction
enzymes as shown in Figure 1A and probed with Ldccys2
coding region as a probe. Identical hybridizing bands
were present in both L. (L.) chagasi and L. (L.) donovani
(Figure 1A). PCR amplification and sequencing of Ldccys2
coding region from L. (L.) donovani genomic DNA
showed identical nucleotide sequences, indicating that L.
(L.) chagasi and  L. (L.) donovani had identical Ldccys2
cysteine protease genes.
Ldccys2 gene is differentially expressed
To study the expression of Ldccys2 cysteine protease genes,
Northern blot analysis was performed using L. (L.) chagasi
total RNA from log and stationary phase promastigotes
and amastigotes. The 3'UTR region of Ldccys2 used as a
probe, hybridized to a 2.5 kb transcript in amastigote (Fig-
ure 1BI) unlike the cysteine protease, Ldccys1, which is
predominantly expressed in promastigote stages of the
parasite (Figure 1 BII). The α-tubulin gene expression was
used as an internal control (Figure 1 BIII). Ldccys2 showed
similar pattern of expression in L. (L.) donovani (data not
shown). It is important to note that this result is in con-
trast to the earlier report (17), wherein Ldccys2 was identi-
fied as promastigote specific cysteine protease gene and
Ldccys1 was thought to be amastigote specific. We have
confirmed the expression pattern and rectified this error
in the following publication (18).
To further confirm the amastigote expression of Ldccys2,
Western blot analysis was carried out using extracts from
both promastigotes and U937 infected amastigotes of L.
(L.) chagasi. The anti-Ldccys2 antibody detected a 30 kDa
band in amastigotes alone (Figure 1C, lane 3).
However, a single 46 kDa band seen in log and stationary
phase promastigotes (Figure 1C, lanes 1 and 2) representsBMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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Ldccys2 is a single copy gene and is expressed only in amastigotes Figure 1
Ldccys2 is a single copy gene and is expressed only in amastigotes. (A) Southern blot hybridization of digested 
genomic DNA from L. (L.) chagasi (Lc) and L. (L.) donovani (Ld). 5 µg of genomic DNA was digested with restriction enzymes as 
mentioned in the figure and blotted onto Hybond-N membranes. The blot was probed with coding region pf Ldccys2 cDNA 
clone. (B) Northern blot analyses of L. (L.) chagasi total RNA. Total RNA (10 µg/lane) from promastigotes of logarithmic (lane 
1), stationary (lane 2) growth phase, U937 cells (human macrophage cell line) infected with promastigotes for 96 h (lane 3) and 
uninfected U937 cells (lane 4) were separated on 1.2% (w/v) formaldehyde agarose gel and transferred on to Hybond N+ 
membrane. Blot was hybridized with PCR amplified DNA fragment containing 3'UTR from Ldccys2 (panel I), Ldccys1 (154 bp, 
near the polyA region, panel II), and coding region of α-tubulin from L. (L.) chagasi, a kind gift from Dr. M.E. Wilson (panel IV). 
(C) Western blot analysis of L. (L.) chagasi promastigotes and amastigotes. Equal amounts of proteins from promastigotes of 
logarithmic (lane 1), stationary (lane 2) phase, U937 cells infected with promastigotes (lane 3) and uninfected U937 cells (lane 
4) were separated on 10% (w/v) SDS-PAGE and blotted on to Hybond – P membrane. Western blot analysis was carried out 
using α-Ldccys2 antibody.BMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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promastigote specific cysteine protease Ldccys1, due to
the cross-reactivity of the antibody. Taken together, the
above results show that Ldccys2 is expressed only in the
amastigote stage of L. (L.) chagasi.
Recombinant Ldccys2 expressed in insect cells is 
functionally active
In order to determine the cysteine protease activity
encoded by Ldccys2, the predicted coding region was
cloned into pIE1/153A.jhe (6hep) vector and transfected
into High Five insect cells (invitrogen). The supernatant
was harvested and analyzed for the presence of recom-
binant protein by Western blot analysis using JHE and
Ldccys2 antibodies. Western blot analyses with α-JHE
antibody (Figure 2A, lane3) detected a band of 96 kDa,
corresponding to the fusion protein. The lower molecular
mass bands are due to the processed products as a result
of autocatalytic activity. Anti- Ldccys2 antibody however,
could not detect the recombinant fusion protein (Figure
2B lane 3). The processed products were detected instead,
which may be because of inaccessibility of the epitope in
the fusion protein. Both the antibodies did not give any
background with the negative control (cell extract, Figure
2B and 2C, lane1). Protease activity determined by gelatin
SDS-PAGE, showed a band of approximately 30 kDa (Fig-
ure 2C, lane 3), confirming the protease activity. Cysteine
protease activity was completely inhibited by a specific
inhibitor, E-64 at 20 µM concentration (data not shown).
Expression of recombinant Ldccys2 using insect cell expression system Figure 2
Expression of recombinant Ldccys2 using insect cell expression system. Western blots showing recombinant 
expression of Ldccys2 using anti-JHE antibody (A) and duplicate blot probed with anti-Ldccys2 antibody (B). The lanes are 
labeled appropriately. 5 µg of supernatant from the insect cells expressing recombinant plasmids or the control were separated 
on 8% SDS-PAGE, blotted onto to PVDF membranes and probed with 1:500 dilution of anti-JHE or 1:100 dilution of anti-
Ldccys2 antibody. A horseradish peroxidase conjugated anti-mouse secondary antibody was used and the blot was developed 
by using ECL chemiluminescent kit. (C) Gelatin assay showing cysteine protease activity of the recombinant protein. The 
supernatant was separated on a gelatin gel and incubated in a reducing buffer. The gel was then stained with Coomassie Blue to 
visualize the clearing of gelatin on the gel indicating cysteine protease activity.BMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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Ldccys2 single allele gene replacement by homologous 
recombination
In order to investigate the function Ldccys2 gene, we have
performed gene replacement by disrupting a 500 bp cod-
ing region of the gene with hyg  and dhfr-ts  cassette as
shown in figure 3A. Following transfection, hygromycin B
resistant parasites (Ldccys2KO, heterozygous knockout
mutants) were selected for further analysis. The PstI
restriction enzyme digested genomic DNA from wild type
L. (L.) chagasi and Ldccys2 KO were subjected to Southern
analysis and results are presented in figure 3B. The dis-
rupted Ldccys2 allele had an additional PstI site that is
present within the hyg gene. As shown in the figure 3B, 5'
and 3'probes (probes a and b) hybridized to a single 3.5
kb band with wild type genomic DNA. In Ldccys2KO,
probe-a hybridized to two bands (3.5 kb and 2.8 kb) and
probe-b hybridized to 3.5 kb and 3.0 kb bands. As
expected, one of the bands corresponds to the wild type
allele whereas the other band corresponded to the dis-
rupted allele. The hyg  specific probe-c resulted in no
hybridizing band with PstI digested wild type genomic
DNA, while in Ldccys2KO, two bands (2.8 kb and 3.0 kb)
corresponding to the disrupted allele were detected (Fig-
ure 3B, probe c). These results clearly indicate that one of
the alleles of the Ldccys2 gene has been replaced by hygro-
mycin gene. Similarly, a second cassette using neomycin
gene was used in order to replace the second allele of
Ldccys2 gene. Despite numerous attempts, we were unable
to obtain a null mutant of Ldccys2. We then checked for
any events of rearrangements or change in ploidy levels in
the heterozygous mutants. No such detectable events were
detected (data not shown).
Ldccys2 single allele knock-out mutants had reduced 
mRNA and protein levels
In order to compare the expression of Ldccys2 gene in wild
type and heterozygous knockout mutants (Ldccys2 KO),
amastigote RNA was isolated from U937 cells infected
with wild type as well as Ldccys2KO mutant L. (L.) chagasi
promastigotes. Northern blot analysis with Ldccys2 cod-
ing region probe detected a single transcript of 2.5 kb
from wild type as well as Ldccys2 KO amastigotes (Figure
4A, panel 1). However, the transcript level of Ldccys2 in
the Ldccys2KO amastigotes was reduced by 64% compared
to that in the wild type L. (L.) chagasi. There was no
change in the level of α-tubulin expression either in the
Ldccys2KO  or in the wild type amastigotes (Figure 4A,
panel 2).
The effect of Ldccys2 single allele disruption at protein
level was studied using western blot analysis. Equal
amounts of lysates from wild type and Ldccys2KO L. (L.)
chagasi amastigotes were analyzed using antiserum raised
against Ldccys2 protein. Wild type L. (L.) chagasi amastig-
otes showed a major band of 30 kDa (Figure 4B, panel 1),
while Ldccys2KO amastigotes showed an identical sized
band, but there was a reduction in amounts by 45%,
based on the quantitation of bands. The antibody did not
pick up any signal from the negative control (U937 cells).
Figure 4B, panel 2 indicates the equal loading of proteins.
These results once again, confirm the deletion of one of
the alleles of Ldccys2.
Ldccys2 single allele gene replacement Figure 3
Ldccys2 single allele gene replacement. (A) Schematic 
representation of the wild type and hyg/dhfr-ts targeted alleles 
of Ldccys2. The location of the PstI sites used to characterize 
the hygromycin B resistant recombinants is shown by 
arrows. The bold lines labelled a, b and c represents the loca-
tion of different probes used in Southern analyses. (B) South-
ern analyses of Ldccys2 heterozygous knockout mutants. 
Genomic DNA (2 µg/lane) from wild type L. (L.) chagasi (WT) 
and Ldccys2 heterozygous knockout mutants (KO) were 
digested with PstI and separated on a 0.9% (w/v) agarose gel. 
The DNA was blotted on to Hybond N+ membrane and 
hybridized with probes a (i), b (ii) and c (iii). Asterisks: 1- rep-
resents wild type allele of Ldccys2 (3.5 kb), 2 and 3- represent 
disrupted allele (3.0 kb and 2.8 kb). The grey lines indicate 
the size of expected bands upon PstI digestion.BMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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Characterization of L. (L.) chagasi heterozygous knockout mutant amastigotes and intra macrophage survival of Ldccys2KO  amastigotes in vitro Figure 4
Characterization of L. (L.) chagasi heterozygous knockout mutant amastigotes and intra macrophage survival 
of Ldccys2KO amastigotes in vitro. (A) Northern blot analysis. Total RNA (10 µg/lane) from U937 cells infected with wild 
type promastigotes, Ldccys2KO and uninfected U937 cells were separated on 1.2% (w/v) formaldehyde agarose gel and trans-
ferred on to Hybond N+ membrane. Blot was hybridized with Ldccys2 coding region DNA probe (1) and α-tubulin gene from 
L. (L.) chagasi (2). (B) Western blot analysis. Equal amount of lysates from U937 cells infected with wild type promastigotes, 
Ldccys2KO promastigotes and uninfected U937 cells were separated on 10% (w/v) SDS-PAGE, blotted on to Hybond P mem-
brane. Panel 1 represents the membrane that was probed with α-Ldccys2 antibody and panel 2 is the duplicate gel stained with 
Coomassie blue. (C) Bar graph showing the number of intracellular amastigotes. U937 macrophage cells were infected at a 
macrophage to parasite ratio of 1:10. The survival of the amastigotes within the macrophages was evaluated every 12 hours by 
cytospin and Diff-Quick staining. (D) Graph showing the percent of total macrophages infected at the given time points. For 
each treatment, 100 infected macrophages were counted. Values represent means ± SEM from three independent 
experiments.BMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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Ldccys2 heterozygous knockout mutants exhibit reduced 
infectivity and intra-macrophage survival of amastigotes
In order to study the effect of Ldccys2 heterozygous
knockout mutants on parasite growth, a growth curve
analysis was performed. No significant differences were
observed between the wildtype parasites and the
Ldccys2KO  (data not shown). Next, we performed an
infection assay with differentiated U937 macrophage cells
using with wild type and Ldccys2KO L. (L.) chagasi pro-
mastigotes. Interestingly, twelve hours after infection, the
number of amastigotes in Ldccys2KO  infected macro-
phages were reduced by half as compared to that of wild
type infected macrophage cells. This trend remained same
at all the time intervals tested (24, 36 and 48 hours post
infection), indicating that the intracellular amastigotes
were not able to multiply efficiently (Figure 4C). The per-
centage of infected macrophages in the wildtype and
Ldccys2KO were similar at 12, 24, 36 and 48 hours post
infection (Figure 4D), however, there was a clear decrease
in the initial infection in case of Ldccys2KO, as compared
to the wildtype parasites. The above data suggests that
Ldccys2 heterozygous knockout has resulted in reduced
levels of Ldccys2 expression and furthermore, has
decreased the ability of the amastigotes to infect the mac-
rophages and survive inside the macrophage cells. Taken
together, these results suggest that Ldccys2 gene has a sig-
nificant role in the infection and intramacrophage sur-
vival of amastigotes.
Antisense mRNA inhibition of Ldccys2 resulted in reduced 
macrophage infection and poor amastigote survival within 
the macrophages
We were unable to generate a complete knock out mutant
of Ldccys2 and the heterozygous knockout mutants only
partially inhibited the gene expression. Therefore, we used
an alternative approach of antisense mRNA inhibition to
silence the Ldccys2 gene and to confirm the conclusions
derived from Ldccys2  heterozygous knockout mutants
studies. Plasmid constructs containing the Ldccys2 anti-
sense and sense sequences were transfected into L. (L.)
chagasi promastigotes. The presence of plasmids in these
transfectants was confirmed by Southern analysis with
Ldccys2 probes (data not shown). Northern blot analyses
of amastigotes expressing different plasmid constructs
were carried out using specific sense and antisense probes.
As expected, Ldccys2 antisense mRNA was expressed only
in amastigotes with antisense constructs (Figure 5A, panel
1), and these amastigotes showed a 74% decrease in the
Ldccys2 mRNA levels (Figure 5A, panel 2). The amastig-
otes containing either the sense plasmid or the control
plasmid did not show any change in the levels of Ldccys2
mRNA (Figure 5A, panel 2). The stained agarose gel indi-
cates the equal amounts of RNA used in the Northern
blots (Figure 5A, panel 3). These results clearly
demonstrate that the episomal expression of Ldccys2 anti-
sense mRNA reduces the levels of endogenous Ldccys2
mRNA.
We next performed Western blot analysis of transfectants
expressing sense and antisense Ldccys2 mRNA using α-
Ldccys2 antibody. Amastigotes expressing antisense
mRNA showed a significant reduction (by 76%) in the
levels of Ldccys2, however, the expression of sense mRNA
did not increase the levels of Ldccys2 compared to amas-
tigotes containing the control plasmid (Figure 5B,
panel1). Equal loading of the protein is depicted by the
Coomassie stained gel (Figure 5B, panel 2). The results
further confirm that Ldccys2 antisense mRNA expression
does inhibit the endogenous levels of Ldccys2.
Survival of L. (L.) chagasi amastigotes within the macro-
phages was assessed in vitro, using U937 cells. Results
from three individual experiments are pooled and the col-
lective data is presented in figure 5C. Results showed that
the amastigotes carrying either the control plasmid (P6.5)
or expressing Ldccys2 sense mRNA did not have any effect
on their capacity to infect and survive inside the macro-
phages. The number of amastigotes per macrophage cell
remained the same at initial stages of infection (data not
shown). However, amastigotes expressing Ldccys2  anti-
sense mRNA showed significant reduction (by almost
50%) in terms of the initial infection and intra macro-
phage survival starting from 12 hours post infection and
remained consistent up to 48 hours after infection (Figure
5D). The percentage of total infected macrophages is
shown in figure 5D. Consistent with the results from the
heterozygous knockout mutants, the Ldccys2  antisense
transfectants had reduced levels of infection when com-
pared to that of the wildtype and control plasmids. These
results further underline the importance of Ldccys2 in
infection of macrophages and subsequent survival of
amastigotes within the macrophage cells. Taken together,
these results indicate that the amastigote specific cysteine
protease, Ldccys2 plays an important role in intramacro-
phage survival of L. (L.) chagasi amastigotes.
Discussion
In this study, we have shown that amastigote cysteine pro-
tease, Ldccys2 necessary for macrophage infection and for
survival of L. (L.) chagasi amastigotes inside the macro-
phage cells using two different approaches, gene disrup-
tion and antisense mRNA expression. Leishmania (L.)
chagasi cysteine protease, Ldccys2 is a single copy gene [18]
and is expressed only in amastigote stage of the parasite.
L. (L.) donovani also possesses an identical gene. Expres-
sion studies performed demonstrates that Ldccys2  is
expressed only in amastigotes of L. (L.) chagasi and L. (L.)
donovani. A similar single copy gene in L. (L.) mexicana
(Lmcpa)  has a significant sequence identity (80%) to
Ldccys2. Lmcpa gene of L. (L.) mexicana which is the closestBMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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Expression of sense and antisense Ldccys2 transcripts in L. (L.) chagasi and survival of wild type, sense and antisense Ldccys2  expressing amastigotes in macrophages Figure 5
Expression of sense and antisense Ldccys2 transcripts in L. (L.) chagasi and survival of wild type, sense and anti-
sense Ldccys2 expressing amastigotes in macrophages. (A) Northern blot analyses of amastigotes expressing sense and 
antisense transcripts. Total RNA (10 µg/lane) isolated from axenic amastigotes of wildtype parasites, transfectants with P6.5/
Ldccys2 sense plasmid and P6.5/Ldccys2 antisense plasmid were separated on 1.2% (w/v) formaldehyde agarose gel and blotted 
on to Hybond N+ membrane. Blots were probed with probes specific for antisense (panel 1) and sense (panel 2) transcripts. 
Panel 3 represents ethidium bromide stained gel. (B) Western blot analysis of sense and antisense Ldccys2 expressing amastig-
otes. Equal amounts of total protein extracted from axenically transformed amastigotes with P6.5/Ldccys2 sense plasmid and 
P6.5/Ldccys2 antisense plasmid and wildtype parasites were separated on 10% (w/v) SDS-PAGE and blotted on to Hybond P 
membrane. The blot was probed with α-Ldccys2 antibody (panel 1) and a duplicate gel was stained with Coomassie blue 
(panel2). (C) Bar graph showing total number of amastigotes within the macrophage cells. U937 macrophage cells were 
infected at a macrophage to parasite ratio of 1:10. The survival of the amstigotes within the macrophages was evaluated every 
12 hours by cytospin and Diff-Quick staining.(D) Graph showing the percent of total macrophages infected at the given time 
points. For each treatment, 100 infected macrophages were counted. Values represent means ± SEM from three independent 
experiments.BMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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homolog of Ldccys2 is differentially expressed in amastig-
otes [23], whereas the Ldccys2 gene of L. (L.) chagasi is
expressed specifically in the amastigote stage. In addition,
the major amastigote specific cysteine proteinase gene of
L. (L.) mexicana,  cpb2.8  is a multicopy gene, located
within the lmcpb cluster [24] and there is no significant
sequence identity (34%) between Ldccys2 and lmcpb2.8.
Therefore, gene organization and expression of amastig-
ote specific cysteine proteases in L. (L.) mexicana and L.
(L.) donovani complex are not identical. Interestingly,
Llacys1, an amastigote specific cysteine protease from L.
(L.) amazonensis was identified recently, which has high
homology (88%) with Ldccys2 and like Ldccys2, is only
expressed in amastigote stages [25]. In order to confirm
the protease activity of amastigote cysteine protease, full-
length Ldccys2 was expressed as JHE-fusion protein in an
insect cell expression system. The recombinant protein
hydrolysed gelatin in activity gels.
Recently, functions of many genes have been established
in  Leishmania  by following gene disruption approach
[26,27]. To study the biological role of Ldccys2 cysteine
protease, we have followed targeted gene disruption using
hyg  gene as the selectable marker. Genomic Southern
analyses of the hygromycin B resistant clones using spe-
cific probes confirmed the replacement of 500 bp region
within the ORF of the Ldccys2 by hyg/dhfr-ts. Northern and
Western blot analyses Ldccys2KO amastigotes showed a
clear decrease in the endogenous levels of Ldccys2 com-
pared to that of wild type L. (L.) chagasi amastigotes (Fig-
ure 4), demonstrating the disruption of one of the Ldccys2
alleles. Despite our repeated effort using different selecta-
ble marker genes, we failed to create a null mutant of
Ldccys2 in L. (L.) chagasi. Since gene amplification and
increase in ploidy level has been reported for Leishmania
species [28], we analyzed for changes in ploidy level and
or gene amplification and found no such events occurring
in these heterozygous knockout mutants. This suggests
that Ldccys2 is an important gene necessary for the initia-
tion of macrophage infection and survival of amastigotes
within the macrophages. Therefore we used the Ldccys2
heterozygous knockout parasites for further functional
studies. The U937 macrophage cells infected with Ldccys2
heterozygous knockout mutants showed a significant
decrease in the initial infection and survival within the
macrophage cells, compared to wild type (Figure 4). This
trend remained consistent from 12 hours up to 48 hours
after infection. The decrease in initiation of infection and
subsequent survival of amastigotes may explain the role of
Ldccys2 in amastigote metabolism and its survival inside
the macrophages [4]. Consistent with our results, null
mutants of the lmcpb cluster in L. (L.) mexicana exhibited
reduction in macrophage infectivity and survival [23].
However, lack of Ldccys2 null mutant prevented us from a
detailed study on the role of Ldccys2 in survival and
pathogenesis, using animal models.
The lack of Ldccys2 null mutants prompted us to use an
alternative approach of antisense mRNA inhibtion in
order to confirm the results obtained from Ldccys2 heter-
ozygous knockout studies. Using antisense RNA tech-
nique it has become possible to investigate the
contribution of cysteine proteases to virulence mecha-
nism of E. histolytica [19,20] and A2- protein in the sur-
vival of L. (L.) donovani amastigotes in macrophages [21].
Furthermore, episomal expression of sense and anti sense
mRNA of L. (L.) amazonensis gp63using Leishmania- spe-
cific P6.5 vector provided evidence for a role both in bind-
ing of macrophages and the intracellular survival and
replication [22]. Not surprisingly, L. (L.) chagasi amastig-
otes expressing Ldccys2 antisense mRNA has clearly down
regulated the endogenous Ldccys2 mRNA levels (Figure 5).
However, a small amount of Ldccys2 mRNA is still present
in antisense transfectants, which may be due to the
incomplete suppression, which is inherent to this
approach. Infection of U937 macrophage cells with trans-
fectants expressing Ldccys2 antisense mRNA showed a sig-
nificant decrease in amastigote survival inside the
macrophage cells, as compared to amastigotes expressing
either sense Ldccys2 mRNA or the control plasmid (Figure
5). This is in agreement with the results obtained from
Ldccys2 heterozygous knockout mutants, reaffirming the
role of Ldccys2 in initiation of intracellular infection, and
subsequent survival and multiplication of amastigotes.
However, the actual effect of antisense mRNA expression
may be greater, since reversal of antisense effects is
expected from the release of the selective pressure neces-
sary to avoid drug toxicity to macrophages [21]. This is
especially true in the assay for intracellular survival and
replication, since it requires prolonged period of incuba-
tion. The transient nature of the antisense suppression in
the absence of selection prevented us from taking up ani-
mal studies that also require prolonged infection with
these transfectants.
The out come of this study shows that Ldccys2 is expressed
only in amastigote stage of the parasite. Both the hetero-
zygous knockout mutants and antisense mRNA expres-
sion shows that Ldccys2 is important for infection of
macrophages and survival of L. (L.) chagasi amastigotes
inside the macrophage cells. Based on the data obtained
in this study, there is a clear justification for targeting the
Ldccys2 gene in L (L.). chagasi and carrying out further
studies in animal models. Currently, we are working
towards generating null mutants of Ldccys2 in L. (L.) cha-
gasi and to further understand the role of this protein in
the pathogenesis of L. (L.) chagasi parasites.BMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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Methods
Parasite culture
L. (L.) chagasi strain MHOM/BR/74/PP75 promastigotes
were grown in HOMEM, pH 7.4 (Gibco BRL) supple-
mented with 10% (v/v) heat inactivated calf serum, at
26°C. Promastigote cultures were seeded at 1 ×
106parasites/ml and harvested in logarithmic or station-
ary growth phase, as defined by cell concentration. L. (L.)
chagasi promastigotes were transformed to axenic amas-
tigotes using the standardized protocol as described ear-
lier [29]. All the transfectants were periodically converted
to amastigotes by infecting U937 macrophage cells in
order to ensure the property of virulence.
RNA isolation and northern hybridization
Total RNA was isolated using trizol (GibcoBRL) as recom-
mended by the manufacturer. Promastigote RNA was
obtained from logarithmic and stationary growth phase
parasites of L. (L.) chagasi. To isolate amastigote RNA,
human macrophage cell line (U937, ATCC) was infected
with promastigote parasites, which were subsequently
converted into intracellular amastigotes [29]. RNA (10 µg/
lane) was separated on 1.2% (w/v) formaldehyde agarose
gels and transferred onto Hybond N+ membrane (Amer-
sham Pharmacia). Standard procedures were followed to
perform Southern and Northern blot hybridizations.
Using Quick Prime Labeling Kit (Amersham Pharmacia
Biotech), probes representing specific region of Ldccys2
cDNA clone was labeled with [α32P] dCTP. The sense and
antisense probes were generated by 5'end-labeling the
specific sense and antisense oligonuecleotide primers
with γ-32P ATP, using T4 polynucleotide kinase according
to the standard protocol.
Polyclonal antibody production against Ldccys2
Direct DNA immunization [30] was used to generate anti-
body against Ldccys2. Briefly, the pro-mature region of
the gene was PCR amplified from the Ldccys2 cDNA clone
using specific 5' (5'CAGACAGGATCCG CGGCCGCCAT-
GGACGACTTCATTGCC 3') and 3' primers (5'
GGCCGCGGATCCGCG GCCGCCTATGAGGTGTT-
GGAGTCGTC 3') and the PCR product was sub-cloned
into BamHI site of pcDNA 3.1 (Invitrogen). After confir-
mation by sequencing the plasmid constructs were ampli-
fied in E. coli and DNA was isolated using endotoxin free
maxi prep kit (Qiagen). 50 µg of plasmid DNA in 100 µl
of saline was injected into the hind limb quadriceps mus-
cles of BALB/c mice. All the mice were boosted after 14
days and tested for antibody response seven days after the
boost. Mice with positive response were boosted one
more time and after a week sera was collected and stored
at -20°C for further use.
Western blot analysis
Denaturing gel electrophoresis was carried out according
to the standard protocols. Following SDS-PAGE, proteins
were transferred onto to Hybond P membrane (Amer-
sham Pharmacia Biotech) using semi-dry transblot appa-
ratus (BioRad). Membranes were blocked for 2 hours with
5% (w/v) skim milk solution and probed overnight at
4°C with 1:200 dilution of anti-Ldccys2 antiserum. Mem-
branes were washed three times with phosphate buffered
saline containing 0.1% (v/v) Tween and incubated with
1:5000 dilution of anti-mouse horseradish peroxidase
linked secondary antibody (Molecular Probes). Enhanced
chemiluminescent kit (Amersham Pharmacia Biotech)
was used for detection.
Expression of cysteine protease genes
In order to express Ldccys2 cysteine protease gene, the cod-
ing region was amplified by PCR. The digested PCR prod-
uct was cloned in-frame into unique NotI site of pIE1/
153A.jhe (6hep) vector [31] and confirmed by sequenc-
ing. The fusion of the Cysteine proteases to the c-terminus
of Juvenile hormone esterase (JHE) directs the secretion
into the culture supernatant of transfected insect cells.
Culture of insect cells and procurement of samples con-
taining recombinant protein from transfected insect cells
are described earlier [32]. Briefly, High Five insect cells
(Invitrogen) were seeded into6-well culture plates (35
mm diameter) at a density of 5 × 105 cells/ml (2 ml/well)
and transfected for 5 h with 0.5 ml of transfection solu-
tion containing 30 µg/ml lipofectin (Life Technologies)
and 6 µg/ml total plasmid DNA in basal IPL-41 medium.
Then the transfection solution was removed, the cells
were rinsed with basal media and 2 ml IPL-41 + 10% FBS
was added and incubated for sixty hours. The supernatant
was then harvested and stored at -20°C for analysis.
Enzyme activity was analyzed on gelatin SDS-PAGE con-
taining 0.2% gelatin and 8% (w/v) acrylamide as
described previously [17]. For inhibition studies, gels
were pre-incubated with 20 µM E-64 (Sigma), a Cysteine
protease specific inhibitor. Gels were stained with
Coomassie Brilliant Blue for half hour and destained with
30% Methanol for 2 hours, to visualize the bands. Bands
were photographed using Diamed apparatus (Bio-Rad).
Ldccys2 gene disruption by homologous recombination
Gene replacement vector, pXLdccys2-HygKO was designed
to replace 500 bp mature region of Ldccys2 coding region
and constructed as outlined below (Figure 2b). The sense
primer Ldccys2 HindIII (5' GCTCTCAAGCTTGCTCACG-
CATCCGCCGC-3') and the antisense primer Ldccys2 Xho
I (5'GAAGGCCTCGAGCGAGCCGCACATTCCCTG-3')
were used to amplify a 500 bp region from Ldccys2 cDNA
and cloned between HindIII – XhoI sites in pX63-Hyg
(kindly provided by Dr. S. M. Beverley) for the 5' end
homologous recombination. A 450 bp 3' endBMC Molecular Biology 2005, 6:3 http://www.biomedcentral.com/1471-2199/6/3
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homologous recombination fragment was amplified
using the sense primer Ldccys2 SmaI (5'CCGGAGCCCG-
GGCCCACGGCGCTTGTGCAG-3') and antisense primer
Ldccys2 BglII (5' ACTGTCAGATCTGCTGTGCGCCA-
GATCGCG-3') and cloned between SmaI and BglII sites of
pX63-Hyg. The plasmid construct pXLdccys2-HygKO was
confirmed by sequencing and digested with HindIII and
BglII. The resulting 3.8 kb linear fragment containing
hygromycin phospotransferase/dihydrofolate reductase-
thymidylate synthase (hyg/dhfr-ts) gene sequence and the
homologous recombination fragment was purified and
used for transfection.
Episomal expression of Ldccys2 specific sense and 
antisense mRNA
The Ldccys2 cDNA clone was isolated from an amastigote
specific cDNA library of L. (L.) chagasi. Ldccys2 was earlier
reported as promastigote specific cDNA clone [17]. How-
ever, it was further verified to be amastigote specific gene
(18). The coding region (1 kb) of Ldccys2 was inserted at
BamHI site of Leishmania specific vector P6.5 [22], a kind
gift from Dr. K.P.Chang. Cloning was done in both sense
and antisense orientations with reference to that of N-
acetylglucosamine 1-phosphate transferase (nagt), which
was used as the selective marker for tunicamycin resist-
ance. Plasmid constructs were confirmed by sequencing.
P6.5 plasmid and the sense and antisense plasmid
constructs were amplified in E. coli and isolated with a
DNA maxi prep kit (Qiagen) and the purified DNA sam-
ples were used for transfection.
DNA transfection
All the transfections were carried out using L. (L.) chagasi
promastigotes. Briefly, 4 × 107 log phase promastigotes
were pelleted, washed twice with phosphate buffered
saline and resuspended in 0.4 ml of electroporation buffer
in a 0.2 cm cuvette. Twenty-five microgram of P6.5 plas-
mid DNA constructs was used for episomal expression,
whereas for homologous recombination 5 µg of linear-
ized DNA fragment was transfected. DNA was electropo-
rated using BioRad Gene Pulser Unit at 0.45 kV,
capacitance of 25 µF and resistance of 250 ohms. Follow-
ing electroporation, cells were resuspended in drug-free
media for 24 hours. Parasites with P6.5 plasmid DNA
constructs were selected for tunicamycin resistance at 5,
10 and 20 µg/ml tunicamycin (Sigma). Parasites trans-
fected with DNA fragment for homologous recombina-
tion were selected for hygromycin B (GibcoBRL)
resistance at 100 µg/ml.
In vitro assay for intra macrophage survival
The U937 macrophage cells were infected with L. (L.) cha-
gasi stationary promastigotes at a host to parasite ratio of
1:10 [33]. Briefly, U937 suspension cells (10 6 cells/ml) in
10 ml RPMI 1640 medium supplemented with 10% (v/v)
heat inactivated fetal bovine serum, 2 mM L-glutamine
and 50 µg gentamycin (Gibco BRL) were allowed to grow
at 37°C for 3 days in 10% (v/v) CO2. The cells were then
induced to adhere with 7.5 ng/ml of phorbol myristate
acetate (PMA) and allowed to recover for 72 hours. The
macrophage cells were then infected with stationary phase
promastigotes and allowed to infect for 6 hours. The
unbound parasites were washed away with RPMI medium
and the infected macrophage cells were fed with fresh
RPMI medium and left for 4 days. At every 12 hours inter-
val up to 72 hours, cells were scraped and Diff-Quick
stained slides were prepared for microscopic counting,
Abbreviations
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